OTCQX:WMMVY - NYSE:WMT - OTCQB:NXTTF - OTCQB:GTBP - PINK:AMFE - OTCQB:TBPMF - OTCQB:DRUS - 24/7 Market News

Venture Breakfast Bits, by 24/7 Market News

2018-09-13T09:21:50+00:00 Sep. 13, 2018 9:18AM EST|

Venture Market News for September 13, 2018

  • Walmart de México y Centroamérica announces the acquisition of Cornershop operations in Mexico

September 13, 2018/ OTC Disclosure & News Service/ Mexico City, DF, Mexico —

Full press release

  • Namaste signs binding terms sheet to acquire UK-based licensed pharmaceutical distribution company AF Trading Ltd.

VANCOUVER, Sept. 13, 2018 /PRNewswire/ - Namaste Technologies Inc. ("Namaste" or the "Company") (TSXV: N) (FRANKFURT: M5BQ) (OTCMKTS: NXTTF) is pleased to announce that the Company's wholly-owned subsidiary, Namaste Bahamas Inc. ("Namaste Bahamas"), has signed a Binding Terms Sheet ("Terms Sheet") to acquire all of the issued and outstanding shares of UK-Based AF Trading Ltd. (operating as "Access Fulfillment" or "accessfulfilment.com"). Access Fulfillment operates a 30,000 square-foot distribution facility in the UK and holds a Wholesale Distribution Authorization (Human) License issued by the Medicines and Healthcare Products Regulatory Agency ("MHRA") which allows Access Fulfillment to distribute pharmaceutical products throughout the UK. The acquisition of Access Fulfillment is the first step in Namaste developing its future medical cannabis distribution platform in the UK, which represents a much larger customer base than that of its Canadian operations. The Company intends to launch a platform similar to its Canadian wholly-owned subsidiary Cannmart Inc. ("Cannmart") within the UK market to help monetize on its database of over 500,000 customers.

Full press release

  • GT Biopharma Announces Postive Results For Two Next Generation Trikes In Solid Tumors

LOS ANGELES, CA / ACCESSWIRE / September 13, 2018 / GT Biopharma Inc. (OTCQB: GTBP) and (Euronext Paris: GTBP) announced today the positive results for two next generation Trispecific Killer Engagers (TriKEs) in solid tumors. These efforts were headed by Dr. Daniel Vallera, Director, Section of Molecular Cancer Therapeutics and Dr. Martin Felices, Co-Director of the Translational Therapy Laboratory at the Masonic Cancer Center, University of Minnesota.

  • Amfil Technologies Inc. Completes Multi-Year Audit and Submits for Uplist to OTCQB, Confirms 2017 Year End Revenues of $8,168,251 and Year Over Year Increase of +3500%

Toronto, ON, Sept. 13, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Amfil Technologies Inc. (OTC: AMFE) is pleased to announce that our company auditors, RBSM LLP, have completed and signed off on the multi-year audit of the company’s financial statements. The company has submitted the required information with the OTC Markets Exchange to up-list from OTC Pink to the OTCQB Venture Market. The company is hopeful that through continued advancement and expansion, a second up-list will occur to the OTCQX Exchange later this year.

Full press release

  • Health Canada Reclassifies Tetra Bio-Pharma’s Inhalation Device Making it Eligible for Reimbursement

ORLEANS, Ontario, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. ("Tetra" or the "Corporation") (TSX VENTURE: TBP) (OTCQB: TBPMF), a global leader in cannabinoid-based drug development and discovery, announced today that Health Canada has re-classified the inhalation pipe device used in the delivery of its PPP001 cannabis drug to a Class 2 Medical Device.  The reclassification will help pave the way towards reimbursement for patients; a key element to patient access and care. The significance of this decision is such that if PPP001 is approved by Health Canada, both the prescription drug and the inhalation device will be eligible for insurance coverage by private and provincial public insurance plans.  Tetra Bio-Pharma is undertaking a Phase III trial with PPP001 treating late stage cancer patients looking to improve quality of life and reduce pain.  The Company also recently announced it is starting a head to head trial to investigate cannabis versus Fentanyl in managing breakthrough cancer pain.

Full press release

  • Drone USA Receives a Surveying Drone Purchase Order from Kentucky's Division of Highway Design

MILFORD, CT / ACCESSWIRE / September 13, 2018 / Drone USA, Inc. (OTCQB: DRUS) (''Drone USA'' or the ''Company''), a service provider and reseller of drones and distributor of products to the U.S. Government, today announced that Drone USA received a purchase order to supply Kentucky's Division of Highway Design with a surveying drone.

Full press release

Connect with 24/7 Market News on social media

https://twitter.com/247MarketNewsHQ

https://www.facebook.com/247MarketNewsHQ/

About 24/7 Market News

As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information.  24/7 MN provides comprehensive corporate communications resources and tools to engage the investment community.

DISCLAIMER:

24/7 Market News (24/7MN) is a third party publisher and news dissemination service provider that produces regular sponsored and non-sponsored reports, articles, stock market blogs, and newsletters covering equities listed on the NYSE, NASDAQ and micro-cap exchanges. 24/7MN holds no investment licenses and is NOT a financial advisory firm, investment adviser, analyst, or broker-dealer and does not undertake any activities that would require such registration. 24/7MN's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.

The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and based on publicly available information which is believed to be reliable. 24/7MN makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice.   24/7MN and/or its affiliates are not responsible for any gains or losses that result from the opinions expressed and are not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks.

For further information on 24/7 Market News, please go to www.247marketnews.com 

Forward-Looking Statements

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan," or "planned," "will," or "should," "expected," "anticipates," "draft," "eventually," or "projected." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and 24/7MN undertakes no obligation to update such statements

CONTACT:

24/7 Market News

Editor@247marketnews.com

Send this to a friend

Hi, this may be interesting you: Kraig Biocraft Laboratories’ New R&D Facility Extends Its Competitive Advantages and Prepares for Large Scale Production! This is the link: https://www.247marketnews.com/kraig-biocraft-laboratories-new-rd-facility-extends-its-competitive-advantages-and-prepares-for-large-scale-production/